Enter
PrivateLast Round
Seed
Mar 8, 2022
Total Funding Raised
$5.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enter operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in March 2022.
Enter is a software company that provides an AI-powered revenue cycle management (RCM) platform for the healthcare industry, designed to automate medical billing, claims processing, and patient collections.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, EHR & EMR, Workflow Automation, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enter Comparables
Compare Enter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cair Health | 86% | |
| ExactRx | 86% | |
| Avion | 84% |
For institutional investors. Book with your work email.
Enter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 8, 2022 | ||||
| Accelerator | Jan 27, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Seed |
| 500 Global | Seed, Accelerator |
| AltaIR Capital | Accelerator |
| SpringRock Ventures | Seed |
| Menlo Ventures | Seed |
| Savantus Ventures | Seed |
| Hard Yaka | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 74% MoM, reaching 18.3K.
- May 12, 2026
Monthly visitors grew 47% MoM, reaching 13K.
For institutional investors. Book with your work email.
Enter Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enter's valuation, stock price, and market status.
Is Enter a public or private company?
Enter is a private company.
What is the current stock price of Enter?
Enter is a private company, so its shares have no public market price. Caplight tracks Enter's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enter worth (valuation)?
Valuation information for Enter is not publicly available.
Can I buy Enter stock?
Enter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enter's last funding round?
Enter's most recent funding round was Seed on March 8, 2022.
Who are the main investors in Enter?
Key investors in Enter include 500 Global, Menlo Ventures.
Will Enter IPO soon?
No public IPO plans have been announced for Enter.
How can I track Enter secondary market activity?
Caplight tracks bids, offers, and trades in Enter's shares on secondary markets.